Latest PEG ratio for Psyence Biomedical Ltd. - Warrants (25/01/2029): -0.0 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow0.00
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for PBMWW is -0.0. That is above the sector sector average of -3.76. Investors often review this figure alongside Psyence Biomedical Ltd. - Warrants (25/01/2029)'s historical trend and sector peers before judging valuation or financial health.
Against its sector companies, PBMWW currently prints -0.0 for PEG ratio, while the sector average sits near -3.76. That is roughly 100.0% above the sector mean. Large gaps often invite a closer look at Psyence Biomedical Ltd. - Warrants (25/01/2029)'s growth, margins, and balance sheet.
A PEG ratio of -0.0 for Psyence Biomedical Ltd. - Warrants (25/01/2029) is not 'good' or 'bad' on its own. Compare it with the peer average (-3.76) and with PBMWW's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting PBMWW's PEG ratio (-0.0), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.